在两名患有结性脊髓炎和同时患有活跃结核病的患者中,sequinumab的治疗经验
Fatih Albayrak1, Nurcihan Y Savaş2, Melis Mutlu3
1Department of Rheumatology, Gaziantep University, Gaziantep, Turkey.
BMJ case reports
|November 12, 2025
概括
患有活跃结核病 (TB) 的性脊柱炎患者可能受益于secukinumab. 这种干白素-17A抑制剂在两种情况下证明了安全性和有效性,在瘤缩因子抑制剂禁用时提供了替代方案.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 瘤坏死因子 (TNF) 抑制剂对结椎炎 (AS) 有效,但会增加结核病 (TB) 的风险.
- 像secukinumab这样的干白素-17A (IL-17A) 抑制剂没有与结核病复激活有关,但它们在活性结核病中的安全性尚不清楚.
研究的目的:
- 评估sequukinumab在AS和活跃结核病患者中的安全性和有效性.
- 评估sequinumab作为一种替代生物疗法,当TNF抑制剂因结核病而禁用时.
主要方法:
- 两名AS患者的病例报告,他们在抗TNF治疗期间发展出活性结核病.
- 在标准的四种药物结核病疗法后2个月开始使用secokinumab.
- 监测AS疾病活动,结核病管理和不良事件.
主要成果:
- 两位患者都通过使用secukinumab.b获得了AS活性的快速和持续控制.
- 在这两位患者中,secukinumab并没有影响结核病的治疗.
- 在1年的随访期间,患者完成了9个月的抗结核治疗,没有任何不良事件或TB重新激活.
结论:
- 当TNF抑制剂禁用时,secukinumab似乎是AS患有活跃结核病的患者的安全和有效选择.
- 需要在更大的研究中进行进一步的调查来证实这些发现.
相关概念视频
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis III
908
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
908
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
Pulmonary Tuberculosis I
816
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
816
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
470
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
470


